Gill Newman appointed Director, Life Sciences Operations

BCD Meetings & Events (BCD M&E) has today announced the appointment of Gill Newman as Director, Life Sciences Operations, EMEA. Gill joins the expanding BCD M&E Life Sciences team from American Express GBT Meetings & Events, where she held the title of EMEA Operations.


Gill will undertake direct line management responsibility for the UK Life Sciences operation, as well as taking a quality and best practice remit for the Life Sciences operation across EMEA. Her time will be split equally across the Maidenhead and Faversham offices, in which she will also provide an essential senior leadership presence.

Nigel Cooper, Managing Director BCD Meetings and Events EMEA commented, “As demand for our Life Sciences services continues to grow, we’re thrilled to welcome Gill to our leadership team. She brings with her a wealth of knowledge and expertise in the Life Sciences sector and further enhances BCD M&E’s standing in the pharmaceutical industry.”


Gill Newman, Director, Life Sciences Operations, EMEA added, “BCD M&E’s reputation speaks for itself and I am very excited to be joining at such a pivotal time for their Life Sciences division. I’m looking forward to working across the EMEA region to deliver an exceptional service for our growing client list.”


Since acquiring Zibrant, BCD M&E has seen solid growth across Europe through the Life Sciences division, globalization of major accounts and new wins in the retail and automotive sectors.